Projects per year
Personal profile
Education
- 1997 國立陽明醫學院生化學研究所博士
- 1991 國立陽明醫學院生化學研究所碩士
- 1987 私立臺北醫學院醫事技術學系學士
Experience
- 2023- Deputy Dean, College of Medical Science and Technology, Taipei Medical University
- 2019- Professor, Ph.D Program in Medical Biotechnology, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2019- Professor, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2017-2022.07 Director, Ph.D Program in Medical Biotechnology, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2017-2022.07 Director, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2015-2019 Associate Professor, Ph.D Program in Medical Biotechnology, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2008-2019 Associate Professor, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 2007-2008 Assistant Professor, Graduate Institute of Medical Science, Taipei Medical University
- 2004-2008 Assistant Professor, School of Medical Loboratory Science and Biotechnology, Taipei Medical University
- 1998-2000 Assistant Professor, Yuan Pei University of Medical Technology
- 1993-1994 Teaching Assistant, Department of Biochemistry, National Yang Ming University
- 1991-1992 Assistant Research Fellow, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital
- 1987-1989 Assistant Research Fellow, Department of Obstetrics and Gynecology, Taipei Veterans General Hospital
Fingerprint
Dive into the research topics where Shu-Huei Kao is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Understanding the Cytoprotective Effects of Mitochondrial-Derived Peptides on Mitochondrial Dysfunction(2/3)
8/1/22 → 7/31/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
粒線體衍生肽對於細胞自噬作用的影響
7/1/22 → 2/28/23
Project: A - Government Institution › b - Ministry of Science and Technology
-
探究粒線體衍胜肽對粒線體功能障礙的細胞保護作用(1/3)
8/1/21 → 7/31/22
Project: A - Government Institution › b - Ministry of Science and Technology
-
探查Pearson氏症候群的基因診斷與在患者衍生細胞上的施行清除粒線體DNA缺失的可行性
8/1/20 → 7/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
ETFDH突變於阿茲海默症之類澱粉前驅蛋白生成和細胞焦亡扮演的角色
7/1/20 → 2/1/21
Project: A - Government Institution › b - Ministry of Science and Technology
-
Osteopontin Splicing Isoforms Contribute to Endometriotic Proliferation, Migration, and Epithelial-Mesenchymal Transition in Endometrial Epithelial Cells
Ho, N. T., Lin, S. W., Lee, Y. R., Tzeng, C. R. & Kao, S. H., Dec 2022, In: International journal of molecular sciences. 23, 23, 15328.Research output: Contribution to journal › Article › peer-review
Open Access -
Serum levels of 4-hydroxynonenal adducts and responding autoantibodies correlate with the pathogenesis from hyperglycemia to Alzheimer's disease
Renuka Sanotra, M., Huang, W. C., Silver, S., Lin, C. Y., Chang, T. C., Nguyen, D. P. Q., Lee, C. K., Kao, S. H., Chang-Cheng Shieh, J. & Lin, Y. F., Mar 2022, In: Clinical Biochemistry. 101, p. 26-34 9 p.Research output: Contribution to journal › Article › peer-review
3 Citations (Scopus) -
Genetic Association in the Maintenance of the Mitochondrial Microenvironment and Sperm Capacity
Thomas, H. I. S., Chen, Y. S., Hung, C. H., Sreerangaraja Urs, D. B., Liao, T. L., Lai, Y. C., Komrskova, K., Postlerová, P., Lin, Y. F. & Kao, S. H., 2021, In: Oxidative Medicine and Cellular Longevity. 2021, 5561395.Research output: Contribution to journal › Article › peer-review
Open Access2 Citations (Scopus) -
Pdia4 regulates β-cell pathogenesis in diabetes: molecular mechanism and targeted therapy
Kuo, T. F., Hsu, S. W., Huang, S. H., Chang, C. L. T., Feng, C. S., Huang, M. G., Chen, T. Y., Yang, M. T., Jiang, S. T., Wen, T. N., Yang, C. Y., Huang, C. Y., Kao, S. H., Tsai, K. C., Yang, G. & Yang, W. C., Oct 7 2021, In: EMBO Molecular Medicine. 13, 10, e11668.Research output: Contribution to journal › Article › peer-review
Open Access9 Citations (Scopus) -
Inhibition of alternative cancer cell metabolism of egfr mutated non-small cell lung cancer serves as a potential therapeutic strategy
Huang, C. Y., Hsu, L. H., Chen, C. Y., Chang, G. C., Chang, H. W., Hung, Y. M., Liu, K. J. & Kao, S. H., Jan 2020, In: Cancers. 12, 1, 181.Research output: Contribution to journal › Article › peer-review
Open Access14 Citations (Scopus)